Show simple item record

dc.contributor.authorTohidkia, MR
dc.contributor.authorBarar, J
dc.contributor.authorAsadi, F
dc.contributor.authorOmidi, Y
dc.date.accessioned2018-08-26T08:05:23Z
dc.date.available2018-08-26T08:05:23Z
dc.date.issued2012
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/49810
dc.description.abstractNowadays, phage display libraries are used as robust tools for discovery and evolution of peptide/protein based drugs as well as targeting molecules, in particular monoclonal antibodies (mAbs) and its fragments (i.e., scFvs, Fabs, or bivalent F(ab')(2)). Phage display technology, as a molecular diversity approach, enables selection of antibody fragments (e. g., scFv/Fab) with high affinity, specificity and effector functions against various targets. However, such selection process itself is largely dependent upon various molecular factors such as methods for construction of phage library, phage/phagemid vectors, helper phage, host cells and biopanning processes. The current review article provides important molecular considerations for successful development of phage antibody libraries that may be used as a platform for translation of antibody fragments into viable diagnostic/therapeutic reagents.
dc.language.isoEnglish
dc.relation.ispartofJOURNAL OF DRUG TARGETING
dc.subjectPhage display
dc.subjectcancer
dc.subjectdrug targeting
dc.subjectmonoclonal antibody
dc.subjectcancer targeting
dc.titleMolecular considerations for development of phage antibody libraries
dc.typeReview
dc.citation.volume20
dc.citation.issue3
dc.citation.spage195
dc.citation.epage208
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.3109/1061186X.2011.611517


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record